Last year was a crucial year of learning for spine and orthopedic leaders, with artificial intelligence understanding and implementation being a top priority for many. Other changes surgeons are ...

Panelists discuss the critical role of effective follow-up and multidisciplinary care in managing hidradenitis suppurativa, emphasizing ongoing patient education, coordinated referrals, and ...

Strengthening patient-centered transitions of care enhances communication and reduces rehospitalization for chronic illness patients across settings.

A PubMed study, “Using patient feedback to drive quality improvement in hospitals,” shows that structured feedback reviews improve processes and deepen trust, especially when leadership is involved.

Primary care clinics achieving higher appointment regularity for patients with chronic conditions exhibited stronger teamwork among the staff and flat organizational structures, supported by ...

Patient navigation was more effective than usual care in increasing follow-up colonoscopy rates after an abnormal stool test result, a new randomized controlled trial revealed. The intervention led to ...

Patient education and navigation significantly improve genomic testing uptake and clinical trial participation, addressing disparities in trial enrollment among underrepresented groups. Video-based ...

Merrill H. Stewart, MD, Ochsner Health, explains how his practice takes advantage of downtime during cardiologist appointments to educate patients. Echocardiograms are important for measuring heart ...

Please provide your email address to receive an email when new articles are posted on . More than 70% of patients requesting assistance identified as African American. Patients who received assistance ...

If you’ve ever been discharged from a hospital or helped a loved one through it, you know how overwhelming it can be. One moment, you’re in a hospital bed, and the next, you’re handed a pile of ...

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced data from the Phase III HARMONi trial featuring the novel, potential first-in-class ...